1. J. B. Kostis, J. J. Raia, Jr., E. A. DeFelice, J. A. Barone, and R. G. Deeter. Comparative clinical pharmacology of ACE inhibitors. In J. B. Kostis and E. A. DeFelice (eds.),Angiotensin Converting Enzyme Inhibitors, Alan R. Liss, New York, 1987 pp. 19–54.
2. R. N. Brogden, P. A. Todd, and E. M. Sorkin. Captopril: An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs 36:540–600 (1988).
3. P. A. Todd and K. L. Goa. Enalapril: A reappraisal of its pharmacology and therapeutic use in hypertension.Drugs 43:346–381 (1992).
4. A. N. Wadworth and R. N. Brogden. Quinapril: A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.Drugs 41:378–399 (1991).
5. G. H. Williams and E. Braunwald. Hypertensive vascular disease. In E. Braunwald, K. J. Isselbacher, R. G. Petersdorf, J. D. Wilson, J. B. Martin, and A. S. Fauci (eds.),Harrison's Principles of Internal Medicine, 11th ed., McGraw-Hill, New York, 1987, pp. 1024–1037.